Keedy, Vicki L.

A randomized, double-blind, placebo-controlled, phase II study of regorafenib vs placebo in advanced/metastatic, treatment-refractory liposarcoma: results from the SARC024 study.

Riedel, Richard F. , Lu, Yao , Attia, Steven , Ganjoo, Kristen N. , Livingston, Michael B. , Ward, John Harris, Rushing, Daniel A., Okuno, Scott H. , Keedy, Vicki L. , Ryan, Christopher W. , Maki, Robert G. , Maki, Robert G , Riedel, Richard F , Ballman, Karla V. , Loggers, Elizabeth T , Chow, Warren , Wright, Jennifer , Reed, Damon R. , Liebner, David A. , Mascarenhas, Leo , Davis, Lara E. , Reinke, Denise K.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11505-11505

10.1200/jco.2018.36.15_suppl.11505